CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.32
+6.28%Margins
Gross margin
61.4%
EBITDA margin
-59.0%
EBIT margin
-70.6%
Net margin
-79.4%
FCF margin
-73.0%
-132.5%
Return on equity
-32.1%
Return on assets
-31.8%
Return on invested capital
0.46x
Asset turnover
-$32.2M
Cash from operations
$1.44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026